"Etanidazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.
| Descriptor ID |
D017341
|
| MeSH Number(s) |
D02.640.672.250 D03.383.129.308.658.250
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Etanidazole".
Below are MeSH descriptors whose meaning is more specific than "Etanidazole".
This graph shows the total number of publications written about "Etanidazole" by people in this website by year, and whether "Etanidazole" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Etanidazole" by people in Profiles.
-
Reply: Pharmacokinetic and Pharmacodynamic Modifiers of EF5 Uptake and Binding. J Nucl Med. 2015 Apr; 56(4):653-4.
-
Comparison of the Hypoxia PET Tracer (18)F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models. J Nucl Med. 2014 Jul; 55(7):1192-7.
-
18F-EF5 PET imaging as an early response biomarker for the hypoxia-activated prodrug SN30000 combined with radiation treatment in a non-small cell lung cancer xenograft model. J Nucl Med. 2013 Aug; 54(8):1339-46.
-
A simplified synthesis of the hypoxia imaging agent 2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[(18)F]pentafluoropropyl)-acetamide ([18F]EF5). Nucl Med Biol. 2012 Oct; 39(7):1012-8.